Trial Profile
Racial Differences in Vagal Control of Glucose Homeostasis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 20 Jun 2022
Price :
$35
*
At a glance
- Drugs Galantamine (Primary) ; Heparin; Soya oil emulsion
- Indications Alzheimer's disease
- Focus Pharmacodynamics; Proof of concept
- Acronyms RDVCGH
- 03 Jun 2022 Primary endpoint has been met. (Change in Oxidative Stress: Baseline to 4 Hours), as per Results published in the Molecular Medicine
- 03 Jun 2022 Primary endpoint has been met. (Change in Oxidative Stress: Baseline to 2 Hours), as per Results published in the Molecular Medicine
- 03 Jun 2022 Results published in the Molecular Medicine